ApoC-II mimetic peptides could also possibly be beneficial in some metabolic diseases, such as in diabetes, in which delivery of TG by lipoproteins to peripheral tissues is known to be impaired [38]. The gene discussed is APOC2; the disease is Other metabolic disease.